Skip to search formSkip to main contentSkip to account menu

feldene capsules

Known as: feldene capsule 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
ovel approach to bioequivalence assessment based on physiologically otivated model
The study was conducted to exemplify an approach capable of obtaining a new insight into bioequivalence (BE) assessment, by the… 
2009
2009
Estudio comparativo de la biodisponibilidad y la bioequivalencia del Piroxicam genérico (Pirodax®) en relación al innovador (Feldene®) en voluntarios sanos
2008
2008
Effect of enhancers on the in vitro percutaneous absorption of piroxicam from compounding formulations Francieli
Formulations of piroxicam in Lanette® (L) or Net Fs® (N) vehicles, with or without permeation enhancers, the ethanol (E) or… 
1991
1991
Comparative pharmacokinetic and bioequivalence studies of suppositories Hotemin® and Feldene® of 20 mg in humans
1986
1986
Double-blind clinical study of Piroxicam as adjuvant in the treatment of the pain and dysfunction of the temporomandibular joints.
This double-blind clinical study analyzes the use of piroxicam as an adjuvant to conservative treatment of patients with pain and… 
1984
1984
Comparison of piroxicam (feldene®) with sulindac in patients with low back pain
1984
1984
Evaluation of piroxicam (Feldene®) as an anti-inflammatory analgesic: a three-part multicentre study in Nigeria. I: Study in acute musculoskeletal disorders
1984
1984
Evaluation of piroxicam (Feldene®) as an anti-inflammatory analgesic, a three part multicentre study in Nigeria. II: Study in sport injuries
1984
1984
An evaluation of piroxican (Feldene®), a new nonsteroidal antiinflammatory agent: a multicentre anglophone West African experience
1983
1983
La pharmacocinétique du piroxicam (feldene®) chez l'homme
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)